Could Patients With Inflammatory Bowel Disease Treated with Immunomodulators or Biologics Be at Lower Risk for Severe Forms of Covid-19?

Posted on May 11, 2020 by Gastroenterology Journal
This entry was posted in News. Bookmark the permalink.